Hepatitis B surface antigen prevalence among people living with HIV in a tertiary hospital in Lagos, Nigeria
The Journal of Infection in Developing Countries · 31.10.2026 · 20 (10) · 1532-1539
DOI: 10.3855/jidc.22034 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infection in Developing Countries, online erschienen am 31.10.2026. Verfasst von Oluwaseyi Sedowhe Ashaka und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences and Biotechnology, Caleb University, Lagos, Nigeria. Hauptthemen laut MEDLINE: Hepatitis B Surface Antigens, HIV Infections, Hepatitis B, Coinfection. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Human immunodeficiency virus (HIV) and hepatitis B virus (HBV) share transmission routes and may interact synergistically, accelerating liver disease and worsening HIV outcomes. This study assessed the prevalence and serological pattern of HBV infection among people living with HIV attending a tertiary health facility in Lagos, Nigeria, providing local evidence to inform integrated screening and prevention strategies. Methodology: A cross-sectional study was conducted among 200 HIV-positive individuals aged 16–65 years attending a tertiary healthcare facility in Lagos, Nigeria, between January and June 2023. Participants recruited included 31 males and 169 females. Samples were screened for hepatitis B surface antigen (HBsAg) using a rapid immunochromatographic test strip. Additional markers (HBsAb, HBeAg, HBeAb, HBcAb) were assessed among HBsAg-positive individuals. Associations were tested using chi-square analysis with significance at p < 0.05, and prevalence estimates were reported with 95% confidence intervals.
Results
HBV/HIV co-infection prevalence was 5.5% (11/200; 95% CI: 2.3–8.7). Co-infection was higher among males, 8.2% (5/61), than among females, 3.6% (6/139), but the difference was not significant (χ² = 1.228, p = 0.268). Highest prevalence occurred among those aged 25–29 years (22.2%; 2/9) and 45–49 years (13.2%; 5/38), although age was not significantly associated with HBsAg positivity (χ² = 13.44, p = 0.062). Among HBsAg-positive participants tested with additional markers (n = 6), HBeAb was detected in four individuals. Dual profiles included HBeAg + HBeAb and HBeAb + HBcAb (each 16.7%).
Conclusions
HBV/HIV coinfection persists in this population, highlighting the need for routine HBV screening, vaccination, and integrated care programs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biological Sciences and Biotechnology, Caleb University, Lagos, Nigeria.
- Department of Haematology and Blood Transfusion, Lagos State University College of Medicine, Ikeja, Lagos, Nigeria.
Zitieren
APA
Ashaka, O. S., Ademola, E. A., Usifoh, S. N., Akpoka, O. A., & Akinbami, A. A. (2026). Hepatitis B surface antigen prevalence among people living with HIV in a tertiary hospital in Lagos, Nigeria. The Journal of Infection in Developing Countries, 20(10), 1532-1539. https://doi.org/10.3855/jidc.22034
Vancouver
Ashaka OS, Ademola EA, Usifoh SN, Akpoka OA, Akinbami AA. Hepatitis B surface antigen prevalence among people living with HIV in a tertiary hospital in Lagos, Nigeria. The Journal of Infection in Developing Countries. 2026;20(10):1532-1539. doi:10.3855/jidc.22034
BibTeX
@article{Ashaka2026,
author = {Ashaka, Oluwaseyi Sedowhe and Ademola, Ebenezer Adewuyi and Usifoh, Success Nduka and Akpoka, Obhioze Augustine and Akinbami, Akinsegun Abduljaleel},
title = {Hepatitis B surface antigen prevalence among people living with HIV in a tertiary hospital in Lagos, Nigeria},
journal = {The Journal of Infection in Developing Countries},
year = {2026},
volume = {20},
number = {10},
pages = {1532--1539},
doi = {10.3855/jidc.22034}
}
EUVIMED